AU4056089A - Method of treating inflammatory disorders by reducing phagocyte activation - Google Patents

Method of treating inflammatory disorders by reducing phagocyte activation

Info

Publication number
AU4056089A
AU4056089A AU40560/89A AU4056089A AU4056089A AU 4056089 A AU4056089 A AU 4056089A AU 40560/89 A AU40560/89 A AU 40560/89A AU 4056089 A AU4056089 A AU 4056089A AU 4056089 A AU4056089 A AU 4056089A
Authority
AU
Australia
Prior art keywords
reducing
inflammatory disorders
treating inflammatory
phagocyte activation
phagocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40560/89A
Inventor
Michael A. Narachi
Carl F. Nathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU4056089A publication Critical patent/AU4056089A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
AU40560/89A 1988-07-20 1989-07-20 Method of treating inflammatory disorders by reducing phagocyte activation Abandoned AU4056089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22257988A 1988-07-20 1988-07-20
US222579 1988-07-20

Publications (1)

Publication Number Publication Date
AU4056089A true AU4056089A (en) 1990-02-19

Family

ID=22832797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40560/89A Abandoned AU4056089A (en) 1988-07-20 1989-07-20 Method of treating inflammatory disorders by reducing phagocyte activation

Country Status (2)

Country Link
AU (1) AU4056089A (en)
WO (1) WO1990000900A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015223A1 (en) * 1990-03-30 1991-10-17 Amgen Inc. Respiratory burst suppression factor
CA2096441A1 (en) * 1990-11-16 1992-05-17 Celtrix Pharmaceuticals, Inc. Heterodimer of b-type transforming growth factors 2 and 3
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6194376B1 (en) * 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US5739107A (en) * 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US6090776A (en) * 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
ATE160486T1 (en) * 1991-08-12 1997-12-15 Nestle Sa FOOD COMPOSITION
CA2116562C (en) * 1991-08-30 1999-04-13 Thangavel Kuberasampath Morphogen-induced modulation of inflammatory response
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
CA2205112C (en) * 1995-09-19 2008-11-18 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
KR20000064752A (en) 1996-03-22 2000-11-06 더 제네랄 호스피탈 코포레이션 Administration of Polypeptide Growth Factor after Expression of Central Nervous System Ischemia or Trauma
AU8492598A (en) * 1997-07-17 1999-02-10 Regents Of The University Of Michigan, The Methods and compositions for tumor reduction
EP2957634A1 (en) * 2014-06-20 2015-12-23 Consejo Superior De Investigaciones Científicas Compounds for prevention and/or treatment of fibrotic diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806523A (en) * 1985-08-06 1989-02-21 Collagen Corporation Method of treating inflammation

Also Published As

Publication number Publication date
WO1990000900A1 (en) 1990-02-08

Similar Documents

Publication Publication Date Title
US5288077C1 (en) Method of progressive jackpot twenty-one
US5364105B1 (en) Method of progressive jackpot twenty-one
AU559545B2 (en) Composition and method for treatment of glaucoma
AU2602188A (en) Method for preventing and treating of thrombosis
AU3371493A (en) Method for improving the quality of sleep and treating sleep disorders
AU3068684A (en) Preparation and method for the treatment of acne
AU3827889A (en) Method of treatment for allergic rhinitis
AU4056089A (en) Method of treating inflammatory disorders by reducing phagocyte activation
AU3300689A (en) Treatment of inflammatory disorders in humans
DE3480181D1 (en) Method of controlling profiling
AU560378B2 (en) Method of controlling pipeline
AU4090289A (en) Method for the treatment of wool
AU4489289A (en) Process for selective manufacture of 2,6-dialkylnaphthalenes
AU3524995A (en) Method for treatment of cancers by regulating the activity of ras proteins
AU2387988A (en) Method of treating skin disorders
EP0493037A3 (en) Method of treating thromboembolic disorders
AU556196B2 (en) Method of controlling branching
AU4028885A (en) A method for the treatment of glaucoma
PL273060A1 (en) Method of transforming pyretroid isomers
AU3611784A (en) Method of treatment
GB2216520B (en) Process for manufacture of methocarbamol
AU646074B2 (en) Method of treating poppy
AU3554089A (en) Compositions and methods for treating cutaneous hyperproliferative disorders
EP0272204A3 (en) Method for controlling the thickness of tubewall
AU4116185A (en) Method of prophylaxis or treatment of atherosclerosis